In further investigation of the cellular mechanisms underlying the observed survival advantage conferred by CD8+CD161+ cells, we analyzed high quality single-cell RNA sequencing (scRNA-seq) data derived from 31 melanoma tumors. The gene discussed is CD8A; the disease is melanoma.